Latest filing published 29 May 2018 for Kiniksa Pharmaceuticals International, plc.
No signal scores available.
Filings by Chris Heberlig span 2 companies, the busiest being Trimeris Inc and Kiniksa Pharmaceuticals International, plc. We count 47 filings; the first trade dates from 27 February 2012 and the latest from 29 May 2018.
Every open-market trade on record is a sale: 24 sales worth €2.3M. The rest of the record consists of 5 share grants and 15 option exercises.
The record was last updated on 29 May 2018 with a transaction in Kiniksa Pharmaceuticals International, plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 46 declarations